First Trust Advisors LP Global Blood Therapeutics, Inc. Transaction History

First Trust Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $1.3 Million - $2.17 Million	58,159 Added 119.16%	106,966 $3.42 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $747,031 - $1.04 Million	29,090 Added 147.54%	48,807 $1.69 Million
Q4 2021 Feb 08, 2022	BUY	$24.9 - $40.26 $490,953 - $793,806	19,717 New	19,717 $577,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.